Ainos, Inc. (AIMD) Insider Trading Activity

NASDAQ$0.726+0.11 (17.74%)
Market Cap
$4.58M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
348 of 849
Rank in Industry
203 of 491

AIMD Insider Trading Activity

AIMD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$21,261
9
50
Sells
$490,033
9
50

Related Transactions

chiang yao-chungdirector
9
$21,261
0
$0
$21,261
TSAI CHUN-JUNGdirector
0
$0
2
$53,510
$-53,510
Taiwan Carbon Nano Technology Corp10 percent owner
0
$0
4
$198,902
$-198,902
lee ting-chuandirector
0
$0
3
$237,621
$-237,621

About Ainos, Inc.

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing …

Insider Activity of Ainos, Inc.

Over the last 12 months, insiders at Ainos, Inc. have bought $21,261 and sold $490,033 worth of Ainos, Inc. stock.

On average, over the past 5 years, insiders at Ainos, Inc. have bought $402,142 and sold $327,072 worth of stock each year.

Highest buying activity among insiders over the last 12 months: chiang yao-chung (director) — $21,261.

The last purchase of 3,500 shares for transaction amount of $7,175 was made by chiang yao-chung (director) on 2026‑06‑05.

List of Insider Buy and Sell Transactions, Ainos, Inc.

2026-06-05Purchasechiang yao-chungdirector
3,500
0.0813%
$2.05
$7,175
-26.67%
2026-06-03Purchasechiang yao-chungdirector
2,000
0.0428%
$2.13
$4,260
-34.77%
2026-05-28Purchasechiang yao-chungdirector
250
0.0046%
$2.30
$575
-47.45%
2026-05-27Purchasechiang yao-chungdirector
2,000
0.0345%
$2.00
$4,000
-43.75%
2026-05-26SaleTaiwan Carbon Nano Technology Corp10 percent owner
41,000
0.8348%
$2.36
$96,760
-54.27%
2026-05-26Salelee ting-chuandirector
109,988
1.8029%
$1.90
$208,977
-54.27%
2026-05-26SaleTSAI CHUN-JUNGdirector
27,718
0.4472%
$1.87
$51,833
-54.27%
2026-05-22Salelee ting-chuandirector
9,302
0.2108%
$1.57
$14,604
-5.23%
2026-05-22SaleTSAI CHUN-JUNGdirector
1,082
0.0242%
$1.55
$1,677
-5.23%
2026-05-21Salelee ting-chuandirector
9,000
0.1963%
$1.56
$14,040
-8.23%
2026-05-19Purchasechiang yao-chungdirector
2,200
0.0527%
$1.68
$3,696
-6.45%
2026-05-18Purchasechiang yao-chungdirector
500
0.011%
$1.65
$825
-12.65%
2026-05-05Purchasechiang yao-chungdirector
129
0.003%
$1.70
$219
-14.45%
2026-04-30Purchasechiang yao-chungdirector
200
0.0046%
$1.68
$336
-14.94%
2026-04-29Purchasechiang yao-chungdirector
100
0.0024%
$1.75
$175
-13.66%
2026-01-28SaleTaiwan Carbon Nano Technology Corp10 percent owner
46,000
1.2177%
$2.17
$99,806
-28.64%
2026-01-09SaleTaiwan Carbon Nano Technology Corp10 percent owner
431
0.009%
$1.86
$802
-17.20%
2026-01-08SaleTaiwan Carbon Nano Technology Corp10 percent owner
850
0.0178%
$1.80
$1,534
-13.69%
2025-10-06SaleTaiwan Carbon Nano Technology Corp10 percent owner
7,000
0.14%
$3.59
$25,130
-54.66%
2025-10-02SaleTaiwan Carbon Nano Technology Corp10 percent owner
2,000
0.0445%
$3.58
$7,170
-50.70%
Total: 518
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
lee ting-chuandirector
807417
10.9346%
$500,598.5414
TSAI CHUN-JUNGdirector
658199
8.9138%
$408,083.3817
chiang yao-chungdirector
11279
0.1527%
$6,992.98100
Paul Tibbits
9417696
127.5407%
$5.84M400
chang wen-handirector
4000000
54.1707%
$2.48M10
MUELLER PETER ROBERTCOO & DIRECTOR OF RESEARCH
1163186
15.7526%
$721,175.3231
CHEN STEPHEN TPresident,Chairman,CEO,CFO
783000
10.6039%
$485,460.003513
CUMMINS JOSEPH MPRES,CEO,CHAIRMAN OF THE BOARD
781724
10.5866%
$484,668.88747
THOMAS R ULIEdirector
771300
10.4455%
$478,206.0010
COY GARY WAYNE
581354
7.8731%
$360,439.48101
tsai chun-hsienCHIEF EXECUTIVE OFFICER
333986
4.5231%
$207,071.3210
Cummins Martin JosephVP,CLINICAL & REGULATORY AFFAI
135966
1.8413%
$84,298.9221
ASE Test, Inc.10 percent owner
58887
0.7975%
$36,509.9410
<0.0001%
Cohen Bernard HVice President & CFO
58836
0.7968%
$36,478.3210
D'ALONZO THOMAS Wdirector
28672
0.3883%
$17,776.6420
MOORE DENNIS DEANdirector
10000
0.1354%
$6,200.0032
PAGE JAMES Adirector
0
0%
$012
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$633,070
27
-5.89%
$2.04M
$117,515
16
-27.38%
$1.66M
$287,718
15
-41.45%
$5.68M
$1,246,170
12
65.67%
$5.42M

AIMD Institutional Investors: Active Positions

Increased Positions9+150%116,997+88.59%
Decreased Positions<1-16.67%522-0.4%
New Positions2New32,996New
Sold Out Positions0Sold Out0Sold Out
Total Postitions14+133.33%248,546+88.19%

AIMD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Renaissance Technologies Llc$103.000.84%58,600+58,600New2025-09-30
Vanguard Group Inc$43.000.35%24,750+24,750New2025-09-30
Two Sigma Investments, Lp$40.000.33%23,008+23,008New2025-09-30
Drw Securities, Llc$31.000.25%17,772+17,772New2025-09-30
Blackrock, Inc.$5.000.04%3,06500%2025-09-30
Tower Research Capital Llc (Trc)$3.000.03%1,810+754+71.4%2025-09-30
Seneschal Advisors, Llc$3.000.03%1,800+1,800New2025-09-30
Steward Partners Investment Advisory, Llc$2.000.02%1,20800%2025-09-30
Citigroup Inc$0<0.01%38+38New2025-09-30
Bank Of America Corp /De/$00%17+9+112.5%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.